Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Faruqi & Faruqi, LLP Launches An Investigation Against Biota Pharmaceuticals, Inc. (BOTA) For Potential Breaches Of Fiduciary



  Faruqi & Faruqi, LLP Launches An Investigation Against Biota
  Pharmaceuticals, Inc. (BOTA) For Potential Breaches Of Fiduciary Duties By
  Its Board Of Directors

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New
York City, is investigating the Board of Directors of Biota Pharmaceuticals,
Inc.

Business Wire

NEW YORK -- October 4, 2013

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national
securities firm headquartered in New York City, is investigating the Board of
Directors of Biota Pharmaceuticals, Inc. (“Biota” or the “Company”) (NasdaqGS:
BOTA) for potential breaches of fiduciary duties in connection with their
conduct in seeking shareholders’ approval for an amendment of the Company’s
2007 Omnibus Equity and Incentive Plan.

Specifically, in the Proxy Statement filed by the Company with the Securities
and Exchange Commission on October 1, 2013, the Board of Directors recommends
that Biota’s shareholders vote to approve an amendment to the Company’s 2007
Omnibus Equity and Incentive Plan to increase the number of shares available
for issuance thereunder from 1,157,978 to 4,157,978. The issuance of the
additional shares could have a substantial dilutive effect on the shares of
Biota common stock.

Request more information now by clicking here: www.faruqilaw.com/BOTA. There
is no cost or obligation to you.

Faruqi & Faruqi, LLP is a national law firm which represents investors and
individuals in class action litigation. The firm is focused on providing
exemplary legal services in complex litigation in the areas of securities,
shareholder, antitrust and consumer litigation, throughout all phases of
litigation. The firm has an experienced trial team which has achieved
significant victories on behalf of the firm’s clients.

If you own common stock in Biota and wish to obtain additional information and
protect your investments free of charge, please visit us at
www.faruqilaw.com/BOTA or contact Juan E. Monteverde, Esq. either via e-mail
at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212)
983-9330.

Contact:

Faruqi & Faruqi, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Juan E. Monteverde, Esq.
jmonteverde@faruqilaw.com
Toll Free: (877) 247-4292
Phone: (212) 983-9330

Attorney Advertising. (C) 2013 Faruqi & Faruqi, LLP. The law firm responsible
for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior
results do not guarantee or predict a similar outcome with respect to any
future matter. We are happy to discuss your particular case.

Contact:

Faruqi & Faruqi, LLP
Juan E. Monteverde, Esq.
(877) 247-4292 or (212) 983-9330
jmonteverde@faruqilaw.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement